Contezolid for treating tuberculous meningitis
Treatments studied
Part of Brain & nervous system, Infections clinical trials.
This trial tests a new antibiotic called contezolid for people with tuberculous meningitis, an infection of the brain lining. The goal is to see if it works well and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with tuberculous meningitis within the past 3 months
- Currently hospitalized
- Willing to use effective birth control during the study and for 1 month after
- No long-term steroid or immunosuppressant use in the last 90 days
- Not pregnant, breastfeeding, or within 6 weeks after giving birth
- No known allergy or previous bad reaction to contezolid or linezolid
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an antibiotic called contezolid for people with bone or joint tuberculosis. It aims to see if the drug can treat the infection effectively.
This trial tests how quickly two antibiotics (tedizolid vs linezolid) can kill tuberculosis germs in the lungs after a first TB infection is suspected. It may help doctors learn which option works faster and safely in the early treatment phase.
This study tests different treatment plans for people with tuberculosis (TB) that can be cured with standard medicines. It aims to find the best treatment for each person based on their risk score, which may lead to shorter or more effective treatment.
This trial tests a combination of TB medicines (B-PaLMZ) for people with HIV who have their first episode of TB meningitis. It aims to find a better treatment option.
This study tests whether a new antibiotic, Contezolid, can quickly reduce the amount of Mycobacterium abscessus in your lungs. It may be a treatment option if you have had a positive sputum test in the past 6 months.
This trial tests a combination of drugs for people with active tuberculosis who have not been treated before. It aims to find a better way to treat TB, even if the bacteria are resistant to some drugs.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.